Molecular Mechanisms Underlying PSD-MAGUK/NMDA Receptor Interactions

PSD-MAGUK/NMDA 受体相互作用的分子机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): The overall objectives of my proposal are to understand the molecular mechanisms by which glutamate receptors, particularly NMDA receptors (NMDARs), interact with synaptic scaffolding proteins and how these interactions shape synaptic transmission. Specifically, I will study how the postsynaptic density-95-like membrane associated guanylate kinase (PSD-MAGUK) protein family, in particular the protein SAP97, traffic NMDA receptors subunits and change their physiology. PSD-MAGUKs and NMDA receptors play a critical role in basal synaptic transmission and learning and memory, and have been implicated in a wide variety of neurological diseases, ranging from developmental disorders such as autism, schizophrenia, to degenerative diseases such as Alzheimer's. My research goals are outlined in two Specific Aims: Specific Aim 1: SAP97 controls AMPA and NMDA receptor trafficking and synaptic morphology. I hypothesize that SAP97 traffics AMPA and NMDARs to synapses during early development and specifically promotes GluN2A-containing NMDARs. Second, I hypothesize that SAP97-mediated signaling also controls dendrite and synapse morphology in developing neurons. I will manipulate SAP97 protein levels in vivo and use electrophysiology and confocal imaging to measure the role of this protein in synaptic transmission and neuronal anatomy. Specific Aim 2: Molecular differences in PSD-MAGUKs underlie NMDAR kinetics and subunit switching. First, I hypothesize that specific protein binding domains shared by PSD-93, -95, and SAP97 promote synaptic trafficking of GluN2A-containing NMDARs while different motifs in SAP102 promote GluN2B- containing receptors. Second, I hypothesize that PSD-MAGUKs also directly influence NMDAR physiology, with each PSD-MAGUK differentially interacting with NMDARs and shaping synaptic currents. I will design and overexpress chimeric PSD-MAGUK proteins in vivo, in NMDAR subunit conditional knockout mice, and measure the effect on NMDARs using electrophysiology. I will also use a heterologous expression system to measure direct interactions between these proteins. Thus, I will define the protein domains responsible for PSD-MAGUK/NMDAR interactions and how these interactions alter NMDAR physiology. These experiments take a multi-dimensional approach to a vital scientific question, combining cutting edge molecular genetic, physiologocial, and anatomical techniques and will enhance our understanding of fundamental molecular mechanisms of synaptic transmission and learning and memory.
描述(由申请人提供):我的建议的总体目标是了解分子机制,谷氨酸受体,尤其是NMDA受体(NMDAR),与突触型支架蛋白相互作用以及这些相互作用如何形成突触传播。具体而言,我将研究突触后密度95样膜相关的鸟苷酸激酶(PSD-Maguk)蛋白质家族如何,尤其是蛋白质SAP97,交通NMDA受体亚基并改变其生理学。 PSD-Maguks和NMDA受体在基础突触传播,学习和记忆中起着至关重要的作用,并且与各种神经系统疾病有关,从自闭症,精神分裂症等发育障碍到诸如阿尔茨海默氏症等退化性疾病。我的研究目标在两个具体目标中概述:特定目标1:SAP97控制AMPA和NMDA受体运输和突触形态。我假设SAP97流量AMPA和NMDAR在早期开发过程中会突触,并专门促进了含Glun2a的NMDAR。其次,我假设SAP97介导的信号传导还控制着发育中的神经元中的树突和突触形态。我将在体内操纵SAP97蛋白水平,并使用电生理学和共聚焦成像来测量该蛋白在突触传播和神经元解剖结构中的作用。特定目标2:PSD-Maguks的分子差异基础NMDAR动力学和亚基转换。首先,我假设由PSD-93,-95和SAP97共享的特定蛋白结合结构域促进了含Glun2a的NMDAR的突触运输,而SAP102中的不同基序则促进了含有Glun2b的受体。其次,我假设PSD-Maguks也直接影响NMDAR生理学,每个PSD-Maguk都与NMDARs差异相互作用并塑造突触电流。我将在体内设计和过表达嵌合PSD-maguk蛋白,在NMDAR亚基有条件敲除小鼠中,并使用电生理学测量对NMDAR的影响。我还将使用异源表达系统来测量这些蛋白质之间的直接相互作用。因此,我将定义负责PSD-Maguk/NMDAR相互作用的蛋白质结构域以及这些相互作用如何改变NMDAR生理学。这些实验采用多维方法来解决一个重要的科学问题,结合了尖端分子遗传,生理社会和解剖技术,并将增强我们对突触传播以及学习和记忆和记忆和记忆和记忆和记忆和记忆和记忆和记忆和记忆基本机制的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MacKenzie A Howard其他文献

MacKenzie A Howard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MacKenzie A Howard', 18)}}的其他基金

Mechanisms of altered synaptic integration and plasticity underlying cellular and circuit dysfunction in genetic epilepsy disorders
遗传性癫痫病中细胞和回路功能障碍的突触整合和可塑性改变的机制
  • 批准号:
    10586117
  • 财政年份:
    2020
  • 资助金额:
    $ 5.57万
  • 项目类别:
Mechanisms of altered synaptic integration and plasticity underlying cellular and circuit dysfunction in genetic epilepsy disorders
遗传性癫痫病中细胞和回路功能障碍的突触整合和可塑性改变的机制
  • 批准号:
    10376364
  • 财政年份:
    2020
  • 资助金额:
    $ 5.57万
  • 项目类别:
Mechanisms of altered synaptic integration and plasticity underlying cellular and circuit dysfunction in genetic epilepsy disorders
遗传性癫痫病中细胞和回路功能障碍的突触整合和可塑性改变的机制
  • 批准号:
    10179505
  • 财政年份:
    2020
  • 资助金额:
    $ 5.57万
  • 项目类别:
Mechanisms of altered synaptic integration and plasticity underlying cellular and circuit dysfunction in genetic epilepsy disorders
遗传性癫痫病中细胞和回路功能障碍的突触整合和可塑性改变的机制
  • 批准号:
    9973980
  • 财政年份:
    2020
  • 资助金额:
    $ 5.57万
  • 项目类别:
Molecular Mechanisms Underlying PSD-MAGUK/NMDA Receptor Interactions
PSD-MAGUK/NMDA 受体相互作用的分子机制
  • 批准号:
    8061587
  • 财政年份:
    2010
  • 资助金额:
    $ 5.57万
  • 项目类别:
Molecular Mechanisms Underlying PSD-MAGUK/NMDA Receptor Interactions
PSD-MAGUK/NMDA 受体相互作用的分子机制
  • 批准号:
    7910286
  • 财政年份:
    2010
  • 资助金额:
    $ 5.57万
  • 项目类别:
Development of Inhibition in the Avian Cochlear Nucleus
禽耳蜗核抑制的发展
  • 批准号:
    7198079
  • 财政年份:
    2006
  • 资助金额:
    $ 5.57万
  • 项目类别:
Development of Inhibition in the Avian Cochlear Nucleus
禽耳蜗核抑制的发展
  • 批准号:
    7113269
  • 财政年份:
    2006
  • 资助金额:
    $ 5.57万
  • 项目类别:
Development of Inhibition in the Avian Cochlear Nucleus
禽耳蜗核抑制的发展
  • 批准号:
    7338006
  • 财政年份:
    2006
  • 资助金额:
    $ 5.57万
  • 项目类别:

相似海外基金

Aberrant Protein Kinase C Signaling in Alzheimer's Disease
阿尔茨海默病中的异常蛋白激酶 C 信号转导
  • 批准号:
    10901015
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
Determining pathogenic PrPC-induced signaling pathways in human iPSC-induced neurons
确定人 iPSC 诱导神经元中致病性 PrPC 诱导的信号通路
  • 批准号:
    10791127
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
Super-Resolution Fluorescence Microscopy of Synaptic Plasticity on Unmodified Brain Slices in Health and Tauopathy
健康和 Tau 病未修饰脑切片突触可塑性的超分辨率荧光显微镜
  • 批准号:
    10729062
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
Uncovering the role of SAP97 in synaptic function and schizophrenia.
揭示 SAP97 在突触功能和精神分裂症中的作用。
  • 批准号:
    10736790
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
Regulation of Synaptic Rhythmicity by Astrocytic Clock
星形细胞钟对突触节律的调节
  • 批准号:
    10715728
  • 财政年份:
    2023
  • 资助金额:
    $ 5.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了